Product Information
CHLD ACETAMINOPHEN 160 MG/5 ML is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.0214 per ML under NDC 45802020126. Its NADAC has been published 637 times since Jun 11, 2014.
The High Outlier badge above means this manufacturer's average price in the Acetaminophen market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
160 mg/5mL
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802020126
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ACETAMINOPHENApproval Type
OTC MONOGRAPH DRUG
FDA Application
M013On Market Since
4/9/2014
Price Statistics
The NADAC for CHLD ACETAMINOPHEN 160 MG/5 ML has been published 637 times since Jun 11, 2014, and over the history we have for it it has risen 9.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0214 per ML |
|---|---|
| All-time high | $0.0261 (Mar 15, 2023) |
| All-time low | $0.0178 (Jul 19, 2017) |
| 52-week high | $0.0217 |
| 52-week low | $0.0192 |
| Median price | $0.0200 |
| Average price | $0.0200 |
| Largest weekly change | +25.7% (Feb 22, 2023) |
| Weeks tracked | 637 |
| Tracking since | Jun 11, 2014 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CHLD ACETAMINOPHEN 160 MG/5 ML?
The current National Average Drug Acquisition Cost (NADAC) for CHLD ACETAMINOPHEN 160 MG/5 ML, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.0214 per ML (NDC 45802020126), effective Aug 19, 2026.
How has the price of CHLD ACETAMINOPHEN 160 MG/5 ML changed over time?
Over the history we have for it, the NADAC for CHLD ACETAMINOPHEN 160 MG/5 ML has risen 9.9%. It has been tracked across 637 weekly CMS publications since Jun 11, 2014.
What are the highest and lowest recorded NADAC prices for CHLD ACETAMINOPHEN 160 MG/5 ML?
Since Jun 11, 2014, the NADAC for CHLD ACETAMINOPHEN 160 MG/5 ML has ranged from a low of $0.0178 (Jul 19, 2017) to a high of $0.0261 (Mar 15, 2023), with a median of $0.0200 per ML.
Are there cheaper alternatives to CHLD ACETAMINOPHEN 160 MG/5 ML?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CHILD PAIN-FEVER 160 MG/5 ML, is $0.0205 per ML — about 4% below CHLD ACETAMINOPHEN 160 MG/5 ML.
Who manufactures CHLD ACETAMINOPHEN 160 MG/5 ML?
CHLD ACETAMINOPHEN 160 MG/5 ML (NDC 45802020126) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.